Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards

Disease Cell Type Therapeutic or Technologysort descending Institution Stage Project Objective Details
UCLA
UCSD
UCLA
UC Davis
Scripps
Cedars-Sinai
UCSD
UCLA
Scripps
UCSD
UCLA
Nanotools Bioscience
Minutia, Inc.
UCLA
UC Irvine
Tenaya Therapeutics, Inc.
Scintillon Inst
Stanford
Gladstone
Leukemia, Acute Myeloid (AML) Cancer Stem Cell Antibody Immune-Onc Therapeutics
Clinical Trial, Phase 1 or Phase 1/2
Severe Combined Immunodeficiency, X-linked (X-SCID) Adult Stem Cell Antibody Jasper Therapeutics, Inc.
Clinical Trial, Phase 1 or Phase 1/2
Heart Disease Adult Stem Cell Antibody UCLA
Pre-IND/IDE or Equivalent
B cell cancers,
Leukemia
Cancer Stem Cell Antibody UCSD
Clinical Trial, Phase 1 or Phase 1/2
Vascular Disease Adult Stem Cell Biologic UCSD
Pre-IND/IDE or Equivalent
Cartilage defect Adult Stem Cell Biologic The Stone Research Foundation for Sports Medicine and Arthritis
Development Candidate, Proof of Concept
Type 1 diabetes iPS Cell Biologic UCLA
Development Candidate, Proof of Concept
Age-related macular degeneration Embryonic Stem Cell Biologic USC
Pre-IND/IDE or Equivalent
Embryonic Stem Cell Cell processing & handling Stanford
Research Insights
COVID-19,
Respiratory Disorders
Other,
Vital Research Opportunity
Convalescent Plasma COH
Research Insights
Kidney Failure Adult Stem Cell Device UC Davis
Pre-IND/IDE or Equivalent
Liver Disease iPS Cell Diagnostic Test UCSF
Development Candidate, Proof of Concept
Beta Thalassemia,
Sickle Cell Disease
Adult Stem Cell Diagnostic Test UCSF
Regulated Lab Test, Ready for Validation
Blood Cancer,
Bone Marrow Transplant and Viral Infection
Adult Stem Cell Donor cell therapy CHLA
Clinical Trial, Phase 1 or Phase 1/2
Dementia iPS Cell Donor cell therapy Gladstone
Development Candidate, Proof of Concept
Brain Injury, hypoxic, ischemic Adult Stem Cell Donor cell therapy Sanford-Burnham
Pre-IND/IDE or Equivalent
Spinal Cord Injury Adult Stem Cell Donor cell therapy UC Irvine
Pre-IND/IDE or Equivalent
Amyotrophic Lateral Sclerosis Adult Stem Cell Donor cell therapy UCSD
Development Candidate, Proof of Concept
Retinitis Pigmentosa Adult Stem Cell Donor cell therapy Cedars-Sinai
Clinical Trial, Phase 1 or Phase 1/2
Intestinal Disease,
Neurological Disorders
iPS Cell Donor cell therapy CHLA
Pre-IND/IDE or Equivalent
Leukemia, Acute Myeloid (AML) Embryonic Stem Cell Donor cell therapy UCSD
Pre-IND/IDE or Equivalent
Age-related macular degeneration Adult Stem Cell Donor cell therapy Stanford
Pre-IND/IDE or Equivalent
B cell cancers,
Leukemia,
Leukemia, Acute Myeloid (AML)
Adult Stem Cell Donor cell therapy Stanford
Clinical Trial, Phase 1 or Phase 1/2
Kidney Failure Adult Stem Cell Donor cell therapy Medeor Therapeutics
Clinical Trial, Phase 3
Spinal Cord Injury iPS Cell Donor cell therapy Stanford
Development Candidate, Proof of Concept
Huntington's Disease Embryonic Stem Cell Donor cell therapy UC Irvine
IND
Stroke Embryonic Stem Cell Donor cell therapy Stanford
Clinical Trial, Phase 1 or Phase 1/2
Pulmonary Hypertension,
Vascular Disease
Adult Stem Cell Donor cell therapy Cedars-Sinai
Clinical Trial, Phase 1 or Phase 1/2
Cartilage defect Embryonic Stem Cell Donor cell therapy USC
IND
Sickle Cell Disease Adult Stem Cell Donor cell therapy COH
Clinical Trial, Phase 1 or Phase 1/2
Kidney Failure Adult Stem Cell Donor cell therapy Stanford
Clinical Trial, Phase 1 or Phase 1/2

Pages

Icon for csv export